Suppr超能文献

体重增加、肥胖与精神药物处方

Weight gain, obesity, and psychotropic prescribing.

作者信息

Nihalani Nikhil, Schwartz Thomas L, Siddiqui Umar A, Megna James L

机构信息

SUNY Upstate Medical University, Syracuse, NY 13210, USA.

出版信息

J Obes. 2011;2011:893629. doi: 10.1155/2011/893629. Epub 2011 Jan 17.

Abstract

A majority of psychiatric medications are known to generate weight gain and ultimately obesity in some patients. There is much speculation about the prevalence of weight gain and the degree of weight gain during acute and longitudinal treatment with these agents. There is newer literature looking at the etiology of this weight gain and the potential treatments being used to alleviate this side effect. The authors undertook a comprehensive literature review in order to present epidemiology, etiology, and treatment options of weight gain associated with antipsychotics, mood stabilizers, and antidepressants.

摘要

众所周知,大多数精神科药物会使一些患者体重增加并最终导致肥胖。关于这些药物在急性治疗和长期治疗期间体重增加的发生率以及体重增加的程度,有很多猜测。有新的文献探讨了这种体重增加的病因以及用于缓解这种副作用的潜在治疗方法。作者进行了全面的文献综述,以介绍与抗精神病药物、心境稳定剂和抗抑郁药相关的体重增加的流行病学、病因及治疗选择。

相似文献

1
Weight gain, obesity, and psychotropic prescribing.
J Obes. 2011;2011:893629. doi: 10.1155/2011/893629. Epub 2011 Jan 17.
2
Psychiatric medication-induced obesity: a review.
Obes Rev. 2004 May;5(2):115-21. doi: 10.1111/j.1467-789X.2004.00139.x.
3
Psychiatric medication induced obesity: an aetiologic review.
Obes Rev. 2004 Aug;5(3):167-70. doi: 10.1111/j.1467-789X.2004.00141.x.
4
Psychiatric medication-induced obesity: treatment options.
Obes Rev. 2004 Nov;5(4):233-8. doi: 10.1111/j.1467-789X.2004.00149.x.
7
Weight considerations in psychotropic drug prescribing and switching.
Postgrad Med. 2013 Sep;125(5):117-29. doi: 10.3810/pgm.2013.09.2706.
10
Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia.
Neuropsychiatr Dis Treat. 2016 Apr 19;12:897-907. doi: 10.2147/NDT.S100405. eCollection 2016.

引用本文的文献

2
Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort.
Transl Psychiatry. 2024 Aug 13;14(1):330. doi: 10.1038/s41398-024-03032-5.
3
Propensity score-matching analysis comparing safety outcomes of appetite-stimulating medications in oncology patients.
Support Care Cancer. 2022 Jul;30(7):6299-6305. doi: 10.1007/s00520-022-07081-8. Epub 2022 Apr 26.
4
Odds of fussy eating are greater among children with obesity and anxiety.
Obes Sci Pract. 2021 Aug 7;8(1):91-100. doi: 10.1002/osp4.548. eCollection 2022 Feb.
5
Increasing Psychiatrists' Role in Addressing the Cardiovascular Health of Patients With Severe Mental Illness.
Focus (Am Psychiatr Publ). 2021 Jan;19(1):24-30. doi: 10.1176/appi.focus.20200036. Epub 2021 Jan 25.
6
Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism .
Saudi Pharm J. 2021 Aug;29(8):917-929. doi: 10.1016/j.jsps.2021.07.006. Epub 2021 Jul 16.
8
Appetite-stimulating effect of gabapentin vs mirtazapine in healthy cats post-ovariectomy.
J Feline Med Surg. 2020 Dec;22(12):1176-1183. doi: 10.1177/1098612X20916391. Epub 2020 May 28.
9
Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.
Clin Infect Dis. 2020 Jul 27;71(3):593-600. doi: 10.1093/cid/ciz853.
10
Risk Factors for Unhealthy Weight Gain and Obesity among Children with Autism Spectrum Disorder.
Int J Mol Sci. 2019 Jul 4;20(13):3285. doi: 10.3390/ijms20133285.

本文引用的文献

1
The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia.
Int J Psychiatry Clin Pract. 2000;4(4):287-91. doi: 10.1080/13651500050517849.
2
Pharmacological management of appetite expression in obesity.
Nat Rev Endocrinol. 2010 May;6(5):255-69. doi: 10.1038/nrendo.2010.19. Epub 2010 Mar 16.
3
Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16.
4
Pharmacologic therapies for obesity.
Gastroenterol Clin North Am. 2010 Mar;39(1):69-79. doi: 10.1016/j.gtc.2010.01.001.
5
Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021.
6
Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
J Affect Disord. 2010 Apr;122(1-2):27-38. doi: 10.1016/j.jad.2009.12.028. Epub 2010 Jan 22.
7
Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
Obesity (Silver Spring). 2010 Sep;18(9):1739-46. doi: 10.1038/oby.2009.478. Epub 2010 Jan 21.
8
Immersion treatment of childhood and adolescent obesity: the first review of a promising intervention.
Obes Rev. 2011 Jan;12(1):37-49. doi: 10.1111/j.1467-789X.2009.00710.x.
9
Drugs in the pipeline for the obesity market.
J Diabetes Sci Technol. 2008 Sep;2(5):913-8. doi: 10.1177/193229680800200525.
10
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder.
Neuropsychiatr Dis Treat. 2009;5:483-90. doi: 10.2147/ndt.s5742. Epub 2009 Oct 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验